Ayala Pollack - Publications, H-index & Citations

Ayala Pollack

Hebrew University of Jerusalem

31H指数

130论文数

2.5K被引数

收录论文 13

发表时间

Re: Singh et al.: Nepafenac 0.3% after cataract surgery in patients with diabetic retinopathy: result of 2 randomized phase 3 studies (Ophthalmology. 2017; 124: 776-785) REPLY

OPHTHALMOLOGY

IF9.5

2018-01-01

OAAI

Singh, Rishi P.; Lehmann, Robert; Martel, Joseph; Jong, Kevin; Pollack, Ayala; Tsorbatzoglou, Alexis; Staurenghi, Giovanni; Cervantes-Coste Cervantes, Guadalupe; Alpern, Louis; Modi, Satish; Svoboda, Liza; Adewale, Adeniyi; Jaffe, Glenn J.

Re: Singh et al.: Nepafenac 0.3% after cataract surgery in patients with diabetic retinopathy: results of 2 randomized phase 3 studies (Ophthalmology. 2017;124:776-785) REPLY

OPHTHALMOLOGY

IF9.5

2018-01-01

OAAI

Re: Re: Singh et al.: Nepafenac 0.3% after cataract surgery in patients with diabetic retinopathy: results of 2 randomized phase 3 studies (Ophthalmology. 2017;124:776-785) REPLY

OPHTHALMOLOGY

IF9.5

2018-01-01

PREAI

Nepafenac 0.3% after Cataract Surgery in Patients with Diabetic Retinopathy

OPHTHALMOLOGY

IF9.5

2017-06-01

OAAI

Singh, Rishi P.; Lehmann, Robert; Martel, Joseph; Jong, Kevin; Pollack, Ayala; Tsorbatzoglou, Alexis; Staurenghi, Giovanni; Cervantes, Guadalupe Cervantes-Coste; Alpern, Louis; Modi, Satish; Svoboda, Liza; Adewale, Adeniyi; Jaffe, Glenn J.

Prospective randomised clinical trial to evaluate the safety and efficacy of nepafenac 0.1% treatment for the prevention of macular oedema associated with cataract surgery in patients with diabetic retinopathy

BRITISH JOURNAL OF OPHTHALMOLOGY

IF3.5

2016-07-07

OAAI

Pollack, Ayala; Staurenghi, Giovanni; Sager, Dana; Mukesh, Bickol; Reiser, Harvey; Singh, Rishi P.

TAK1 Inhibition Accelerates Cellular Senescence of Retinal Pigment Epithelial Cells

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE

IF4.7

2014-09-08

PREAI

Dvashi, Zeev; Green, Yaron; Pollack, Ayala